A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Trial details
- Registry ID
- NCT07284758
- Drugs studied
- Cemsidomide, Dexamethasone
TrialRedline tracks 1 clinical trial sponsored by C4 Therapeutics, Inc.: 1 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple MyelomaNCT07284758 | Cemsidomide, Dexamethasone | Recruiting | 2030-03Estimated |
Names as written in the registry records.
NCT07284758 · C4 Therapeutics, Inc.
Before: Not yet recruiting. After: Recruiting.